Effects of vasoactive intestinal peptide on prolactin secretion in three species of passerine birds.
Previous work on domesticated species has indicated that vasoactive intestinal peptide (VIP) is an important prolactin-releasing factor in these birds, but no comparative work in passerine birds has been reported. This study showed that iv injections of VIP (50-100 microg/kg body mass) result in a dramatic, but transitory, rise in plasma prolactin in Mexican jays (Aphelocoma ultramarina). Significant increases in prolactin were also observed following VIP injection in blue jays (Cyanocitta cristata) and zebra finches (Poephilla guttata). At the dosage we used, maximum levels of prolactin attained were slightly lower (Mexican jays) or very similar (blue jay and zebra finch) to the maximum prolactin levels observed in other, breeding birds of the same species. In zebra finches that initially had low prolactin, VIP injection resulted in a greater than 10-fold increase in prolactin within 10 min, but those individuals that already had elevated prolactin showed no further increase in response to VIP. Slow-release pellets of VIP implanted subcutaneously in Mexican jays and releasing 10 or 15 microg VIP/day (two or three pellets) produced a significant increase in plasma prolactin (78 and 92% rise, respectively) compared to birds with placebo pellets or with with one pellet releasing only 5 microg/day.
Vleck
C M
CM
Department of Zoology and Genetics, Iowa State University, Ames, Iowa, 50011, USA.
Patrick
D J
DJ
D000818:Animals; D004343:Drug Implants; D005260:Female; D008297:Male; D011388:Prolactin / Q000378:metabolism*; D011863:Radioimmunoassay; D020308:Songbirds / Q000378:metabolism*; D014660:Vasoactive Intestinal Peptide / Q000008:administration & dosage / Q000494:pharmacology*
D004343:Drug Implants; D014660:Vasoactive Intestinal Peptide; D011388:Prolactin